Skip to main content
. Author manuscript; available in PMC: 2019 Feb 28.
Published in final edited form as: Chem Rev. 2018 Jan 11;118(4):1599–1663. doi: 10.1021/acs.chemrev.7b00504

Figure 2.

Figure 2

Oligonucleotide modifications and delivery strategies. (A) Common oligonucleotide modifications. (B) Lipid nanoparticle delivery systems. (C) GalNAc conjugated oligonucleotides for targeted delivery to the liver.